feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

BioArctic: Initial kommentar om Leqembiförsäljning (Q4 2023)

Research Note

2024-02-06

13:50

Redeye ger en kort kommentar om försäljningssiffrorna för Leqembi under Q4 2023, som var lägre än väntat.

FT

Fredrik Thor

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.